The Initiation of Vesicant Skin Injury at a Single Cell Level
单细胞水平上起泡性皮肤损伤
基本信息
- 批准号:10708030
- 负责人:
- 金额:$ 23.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-21 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AbbreviationsAcetylcysteineAnimal ModelAntioxidantsArsenicArsenicalsBasal laminaBiochemicalBullaCellsChemical StructureChemical WarfareChromatinCollagenCyclic GMP-Dependent Protein KinasesDermalEpidermisFoundationsGenesGenetic TranscriptionGenomicsGoalsHistologicHumanImageImiquimodInjuryInterferonsKnowledgeLangerhans cellLate EffectsLeadMechlorethamineMetabolicMetabolismMethodsModelingMonitorMusMustardMustard CompoundsMustard GasNatureNitric OxideNitrogenNuclearOxidantsOxidative StressOxidesOxygenPathogenesisPathogenicityPeroxonitritePhasePublishingReactive Nitrogen SpeciesReactive Oxygen SpeciesResearchRoleSkinSkin injurySkin repairStructureSulfidesSuperoxide DismutaseTechnologyTerrorismTestingTimeToxic effectTransplantationVesicantsWorkcell injurycobinamideeffectiveness testingefficacy testingexperimental studyfluorescence lifetime imagingin vivoin vivo evaluationin vivo fluorescenceinnovationinsightkeratinocytelewisitemouse modelnovel therapeutic interventionnovel therapeuticsoxidative damageresponsesingle-cell RNA sequencingskin damagetoolwound healing
项目摘要
Abstract
Sulfur mustard (mustard gas) and arsenicals such as lewisite are major threats as chemical warfare or terrorist
agents. Despite different chemical structures, both types of agents lead to similar skin damage with large blisters
and wounds that heal slowly, raising the specter of shared pathogenic mechanisms. In this proposal, we will
investigate the role of oxidant skin injury as a shared mechanism in mustard and arsenical vesicant injury,
employing nitrogen mustard and phenylarsine oxide as surrogates for sulfur mustard and lewisite, respectively.
Although major advances have been made in vesicant research, we still do not have effective counter agents.
This may be in part due to lack of full understanding of the pathogenesis of vesicants. The overarching hypothesis
of this proposal is that defining the early effects of vesicants in vivo at subcellular and single cell levels will refine
our understanding of the role of oxidative stress in vesicant skin injury and lead to new therapeutic strategies.
We will also test the hypothesis that cobinamide, a highly effective and versatile antioxidant that neutralizes both
reactive oxygen and nitrogen species, will be effective as a counter-agent and as means to understand better
the role of oxidative stress in nitrogen mustard- and phenylarsine oxide-induced vesicant injury. The specific
aims are: 1) To understand the initiation of nitrogen mustard- and phenylarsine oxide-induced skin injury
at a single cell level. We will use in vivo fluorescence lifetime imaging (FLIM) and single cell RNA sequencing
to gain a new view on the initiation of vesicant injury and the role of oxidative stress in the pathogenesis. 2) To
define the efficacy of cobinamide against nitrogen mustard- and phenylarsine oxide-induced vesicant
skin injury. We will test the efficacy of cobinamide against nitrogen mustard- and phenylarsine oxide-induced
vesicant skin injury in mice. Due to differences between mouse and human skin, we will also investigate vesicant
mechanisms in transplanted human skin. These studies are significant and innovative because they use state of
the art tools to investigate a gap in our knowledge about the role of oxidative stress in the initiation of mustard
and arsenical vesicant injury and because they test for the first time cobinamide, a highly effective antioxidant
that is bifunctional for reactive oxygen and nitrogen species.
抽象的
硫磺(芥末气)和诸如路易斯特等砷是化学战或恐怖分子等主要威胁
代理商。尽管化学结构不同,但两种类型的药物都会导致皮肤损伤相似
并恢复缓慢的伤口,增加了共同致病机制的幽灵。在此提案中,我们将
研究氧化剂皮肤损伤作为芥末和砷囊泡损伤中的共享机制的作用,
分别用氮芥末和氧化苯胺作为硫酸盐和刘易斯石的替代物。
尽管在Vesicant研究中已经取得了重大进展,但我们仍然没有有效的反击代理。
这可能部分是由于缺乏对囊泡的发病机理的完全理解。总体假设
该建议的是,在亚细胞和单细胞水平上定义体内囊泡的早期作用将完善
我们对氧化应激在囊泡皮肤损伤中的作用的理解并导致新的治疗策略。
我们还将检验以下假设,即哥竞胺是一种高效且多才多艺的抗氧化剂,可中和
活性氧和氮种将是一种反代理,可以更好地理解更好的方法
氧化应激在氮芥末酱和苯胺氧化物诱导的囊泡损伤中的作用。具体
目的是:1)了解氮芥末芥末和氧化苯胺诱导的皮肤损伤的启动
在单个单元格级别。我们将使用体内荧光寿命成像(FLIM)和单细胞RNA测序
为了对囊泡损伤的启动以及氧化应激在发病机理中的作用获得新的看法。 2)到
定义核酰胺对氮芥末芥末和苯烷氧化物诱导的囊泡的疗效
皮肤损伤。我们将测试核酰胺对氮芥末和氧化苯胺诱导的疗效
小鼠的囊泡皮肤损伤。由于小鼠和人皮之间的差异,我们还将研究囊泡
移植的人皮中的机制。这些研究具有重要和创新性,因为它们使用
我们了解氧化应激在芥末启动中的作用的差距的艺术工具
和砷囊泡损伤,并且因为它们首次测试了核酰胺,所以高效的抗氧化剂
这对于活性氧和氮种是双功能的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bogi Andersen其他文献
Bogi Andersen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bogi Andersen', 18)}}的其他基金
Interdisciplinary Training Program in Skin Biology
皮肤生物学跨学科培训项目
- 批准号:
10612438 - 财政年份:2022
- 资助金额:
$ 23.6万 - 项目类别:
The Initiation of Vesicant Skin Injury at a Single Cell Level
单细胞水平上起泡性皮肤损伤
- 批准号:
10511732 - 财政年份:2022
- 资助金额:
$ 23.6万 - 项目类别:
Interdisciplinary Training Program in Skin Biology
皮肤生物学跨学科培训项目
- 批准号:
10410209 - 财政年份:2022
- 资助金额:
$ 23.6万 - 项目类别:
相似国自然基金
乙酰半胱氨酸通过PI3K/AKT/mTOR通路增强CAR-CIK的抗肿瘤作用和机制研究
- 批准号:82303762
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
N-乙酰半胱氨酸介导线粒体SIRT3活化促进老年骨质疏松性骨修复的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
N-乙酰半胱氨酸介导线粒体SIRT3活化促进老年骨质疏松性骨修复的机制研究
- 批准号:82272494
- 批准年份:2022
- 资助金额:53.00 万元
- 项目类别:面上项目
基于自噬研究N-乙酰-L-半胱氨酸促进毕赤酵母分泌重组猪促卵泡素的作用机制
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于自噬研究N-乙酰-L-半胱氨酸促进毕赤酵母分泌重组猪促卵泡素的作用机制
- 批准号:32102542
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Sensitive and Treatable Periods of Brain-Redox Imbalance in Schizophrenia
精神分裂症脑氧化还原失衡的敏感期和可治疗期
- 批准号:
8468212 - 财政年份:2010
- 资助金额:
$ 23.6万 - 项目类别:
Sensitive and Treatable Periods of Brain-Redox Imbalance in Schizophrenia
精神分裂症脑氧化还原失衡的敏感期和可治疗期
- 批准号:
7980131 - 财政年份:2010
- 资助金额:
$ 23.6万 - 项目类别:
Sensitive and Treatable Periods of Brain-Redox Imbalance in Schizophrenia
精神分裂症脑氧化还原失衡的敏感期和可治疗期
- 批准号:
8113251 - 财政年份:2010
- 资助金额:
$ 23.6万 - 项目类别: